Director/PDMR Shareholding

RNS Number : 4347N

Assura PLC

31 May 2022

 

31 May 2022

Assura plc

("the Company")

Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs") and connected persons

The Company announces the following transactions in respect of Ordinary Shares of 10 pence each in the Company ("Ordinary Shares"):

· Jayne Cottam's spouse has acquired 52,500 Ordinary Shares at 71.42p and 700 Ordinary Shares at 71.25p.

Following the transactions, the total beneficial interest of Jayne Cottam and her connected persons in the Ordinary Shares is 488,723.

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jayne Cottam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Purchase of shares by spouse
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.7142 GBP 52,500
d)	Aggregated information -  Aggregated volume -  Price	Aggregate Price Aggregate Volume Aggregate Total £0.7142 GBP 52,500 £37,495.50 GBP
e)	Date of the transaction	30/05/2022
f)	Place of the transaction	XLON

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Jayne Cottam
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Assura plc
b)	LEI	21380026T19N2Y52XF72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10 pence each GB00BVGBWW93
b)	Nature of the transaction	Purchase of shares by spouse
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.7125 GBP 700
d)	Aggregated information -  Aggregated volume -  Price	Aggregate Price Aggregate Volume Aggregate Total £0.7125 GBP 700 £498.75 GBP
e)	Date of the transaction	31/05/2022
f)	Place of the transaction	XLON

- Ends -

For further information, please contact:

Assura plc Orla Ball, Company Secretary David Purcell, Investor Relations Director	Tel: [phone] E mail: [e-mail]
Finsbury Glover Hering Gordon Simpson James Thompson	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which almost seven million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2022, Assura's portfolio was valued at £2,752 million.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

 

END

 

 

DSHBDGDURUXDGDB